Ultrasound (US) Guided External Ventricular Catheter Placement

June 4, 2026 updated by: Chris Zacko, Milton S. Hershey Medical Center
To assess the accuracy the SOLOPASS® System US based in the placement of external ventricular drain into the cranial cavity. This study will aim at evaluating the proposed efficacy of the device in targeting the brain ventricles and decrease multiple brain passes, incorrect deployment and malfunctioning of the drain.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Pennsylvania
      • Hershey, Pennsylvania, United States, 17033
        • Recruiting
        • Penn State Health Milton S. Hershey Medical Center
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Decision made to perform the procedure by the primary consultant
  • Age 18 or older
  • Neuro ICU stay
  • Newly diagnosed hydrocephalus
  • Has a recent CT within the past 24 hrs
  • Normal platelets and coagulation profile
  • No active infection or currently on antibiotics
  • The targeted fluid compartment has more than 50 percent CSF vs blood by CT scan imaging

Exclusion Criteria:

  • Age <18
  • Not in Neuro ICU setting
  • Previous placement of a ventricular catheter
  • More than 50 percent of the fluid compartment is filled with blood by CT scan
  • Time to include in the trial prohibited by clinical personnel

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Catheter placement with Solopass system
The Solopass US system will be used during catheter placement procedure to guide the placement of the catheter.
This device is used as a guidance for placing a brain catheter to target the brain ventricles and decrease multiple brain passes, incorrect deployment and malfunctioning of the drain.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Average number of passes needed to place the catheter in each subject.
Time Frame: 0 minutes
Measured by the number of passes needed to place the catheter. If the first attempt fails, another US sweep will be performed, and another attempt will be performed. If that fails, then the procedure will be aborted.
0 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post procedure imaging accuracy of the placement of the EVD will be performed by reviewing post procedure imaging using the Kakarla scoring system
Time Frame: up to 7 days
Grade 1 means optimal placement in the ipsilateral frontal horn or third ventricle; Grade 2 means a functional placement in the contralateral lateral ventricle or no eloquent cortex; and Grade 3 means suboptimal placement in the eloquent cortex or nontarget cerebrospinal fluid space, with or without functional drainage
up to 7 days

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of time of the procedure
Time Frame: Up to three hours
Number of minutes necessary to complete the procedure placement of the catheter
Up to three hours
Number of revision
Time Frame: up to 7 days
Quantity of revisions due to the catheter malfunction
up to 7 days
Number of subjects with Cerebrospinal fluid (CSF) infection
Time Frame: up to 7 days
CSF will be collected as part of standard of care after the procedure and tested for infection.
up to 7 days
Number of subjects with Superficial surgical site infection (SSI)
Time Frame: up to 7 days
(The CDC defines SSI as deep and superficial. A superficial incisional SSI is an infection in the area of the skin where the incision was made. A deep incisional SSI occurs beneath the incision area in the muscle and the tissues surrounding the muscles. Signs to be monitored daily and put in a checklist will include redness, pain, unexplained fever source, pain, warmth, pus or swelling.)
up to 7 days
Longevity of the device function
Time Frame: up to 7 days
Number of days until a subsequent catheter is placed
up to 7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: J C Zacko, MD, Milton S. Hershey Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

January 22, 2024

First Submitted That Met QC Criteria

February 2, 2024

First Posted (Actual)

February 12, 2024

Study Record Updates

Last Update Posted (Actual)

June 5, 2026

Last Update Submitted That Met QC Criteria

June 4, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00022095

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe